CLINICAL_TRIALS
trial_result
· 2015-10-29
Clinical Trial Update: A Pharmacokinetic Study of MK-3102 in Participants With Impaired Hepatic Function (MK-3102-031) [Phase 1]
Summary
Phase 1 pharmacokinetic study of MK-3102 in participants with impaired hepatic function completed; results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2015-10-29